3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Other solid neoplasm
1
Gastrointestinal
1
Conditions
Colorectal Neoplasms
5
Rectal Neoplasms
4
Colonic Neoplasms
2
Small Cell Lung Carcinoma
1
Sarcoma
1
Metastatic Solid Malignancies
1
Mesothelioma, Malignant
1
Anus Neoplasms
1
Interventions
tislelizumab
1
technetium-diethylenetriaminepentaacetic acid-mannosyl-dextran
1
regorafenib
1
Sentinel Lymph Node Biopsy
1
Magnetic Resonance Spectroscopy
1
Blood Specimen Collection
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Withdrawn
×
Anus Neoplasms
×
regorafenib
×
Clear all
NCT05582031
2023-06-07
REFIT-MSS
Translational Research in Oncology
Phase 2
Withdrawn